• Home
  • Lab members
    • Current members
    • Past members
    • Visiting scientists
    • Photogallery
  • Selected Publications
  • Research
    • Study Cohorts >
      • ETUDE INNODIA
    • Projects
    • Milestones
    • Science photos
    • Science videos
  • Links
    • Journals
    • Our sponsors
    • Societies
  • Pour les patients
    • NOS DOSSIERS "Parlons science"
    • ETUDE INNODIA >
      • Centres INNODIA France
      • Instructions pour les participants
      • Témoignages
    • Liens utiles - Useful links
    • Soutenez-nous - Support Us >
      • Version française
      • English version
  • Contact
  The dear lab
The DeARLab - Diabetes & Autoimmunity Research Laboratory
Picture

LATEST PUBLICATIONS

Presumption of guilt of T cells in type 1 diabetes: lead culprits or partners in crime depending on age of onset?
​Carré A , Richardson SJ, Etienne Larger, Mallone R
Diabetologia 2021
Peptides Derived From Insulin Granule Proteins are Targeted by CD8+ T Cells Across MHC Class I Restrictions in Humans and NOD Mice
Azoury ME, Tarayrah M, Afonso G, Pais A, Colli ML, Maillard C, Lavaud C, Alexandre-Heymann L, Gonzalez-Duque S, Verdier Y, Vinh J, Pinto S, Buus S, Dubois-Laforgue D, Larger E, Beressi JP, Bruno G, Eizirik DL, You S, Mallone R,
Diabetes 2020
Presumption of innocence for beta cells: why are they vulnerable autoimmune targets in type 1 diabetes?
Mallone R, Eizirk DL 
Diabetologia 2020
T-Cell Epitopes and Neo-epitopes in Type 1 Diabetes: A Comprehensive Update and Reappraisal
James EA, Mallone R, Kent SC, DiLorenzo TP
Diabetes 2020

Conventional and Neo-Antigenic Peptides Presented by β Cells Are Targeted by Circulating Naïve CD8+ T Cells in Type 1 Diabetic and Healthy Donors
​Gonzales-Duque S, Azoury ME, Colli ML, Afonso G, Turatsinze JV, Nigi L, Lalane AI, Sebastiani G, Carré A, Pinto S, Culina S, Crocos N, Bugliani M, Marchetti P, Armanet M, Diedisheim M, Kyewski B, Steinmetz LM, Buus S, You S, Dubois-Laforgue D, Larger E, Beressi JP, Bruno G, Dotta F, Scharfmann R, Eizirik DL, Verdier Y, Vinh J, Mallone R
Cell Metab 2018
Picture

Islet-reactive CD8+ T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors
Culina S, Lalanne AI, Afonso G, Cerosaletti K, Pinto S, Sebastiani G, Kuranda K, Nigi L, Eugster A, Osterbye T, Maugein A, McLaren JE, Ladell K, Larger E, Beressi JP, Lisina A, Appay V, Davidson HW, Buus S, Price DA, Kuhn M, Bonifacio E, Battaglia M, Caillat-Zucman S, Dotta F, Scharfmann R, Kyewski B, Mallone R, ImMaDiab Study Group
​
Sci Immunol 2018


Immagine
Picture
Bienvenus sur le site du Laboratoire DeARLab
​
Le Laboratoire de Recherche sur le Diabète et l’Auto-immunité (DeARLab) a été établi en 2007 à l'Institut Cochin. Il est affilié à l’Inserm (Institut National de la Santé et de la Recherche Médicale) , à l’Université Paris Descartes et à l’Assistance Publique/Hôpitaux de Paris. 
En 2008, il est devenu équipe "Avenir", un label d’excellence attribué par l’Inserm à des jeunes équipes qui lancent une thématique de recherche nouvelle et prometteuse.
 
Notre objectif est de comprendre la pathogenèse immunitaire du diabète de type 1 et d’autres maladies auto-immunes. Grâce à des technologies innovantes, nous visons à développer des protocoles de suivi et intervention immunologique pour la classification diagnostique, le traitement et la prévention des maladies auto-immunes.
 
Bonne visite !


Roberto Mallone, MD PhD
​Sylvaine You, PhD

​

Picture

Welcome to the DeARLab Website

The Diabetes & Autoimmunity Research Laboratory was established in 2007 at the Cochin Institut. It is affiliated with Inserm (Institut National de la Santé et de la Recherche Médicale), the University Paris Descartes and the Assistance Publique/Hôpitaux de Paris.

In 2008, it received the "Avenir" label, a prestigious honor assigned by Inserm to young research groups starting a novel high-impact line of research.

Our focus is the understanding of the immune pathogenesis of type 1 diabetes and other autoimmune disorders. Through development of innovative technologies, we aim at obtaining "immune staging" protocols for diagnostic classification, treatment and therapeutic prevention of autoimmune diseases.

Hope you will enjoy your visit!

Roberto Mallone, MD PhD
​Sylvaine You, PhD

aa
Découvrez les projets du Service de Diabétologie de l’Hôpital Cochin ​
Soutenez-nous
Etude Innodia Cliquer ici
19th Immunology of Diabetes Society (IDS) Congress Paris 2023
​
The 19th Immunology of Diabetes Society (IDS) Congress meeting will take place in Paris, France from May 23-27, 2023. This has been the Congress of reference in the field of type 1 diabetes autoimmunity and beyond for over 25 years. Please check the exceptional roster of speakers that will be presenting the latest updates in the field.

For more information and to register, please visit https://www.idsparis2023.com/.

 
Early bird registration deadline: Feb 15th 2023
Abstract submission deadline: Feb 15th 2023
Late registration deadline: March 15th 2023

​

OUR PARTNERS

Photo
Immagine
Immagine
Photo

Powered by Create your own unique website with customizable templates.